Suchergebnisse - "Buti, Maria"

PubPharm (29)

1

Editorial : pegylated interferon combined with bulevirtide for chronic hepatitis delta-new life for an old timer?

enthalten in: Alimentary pharmacology & therapeutics | 2022

von Riveiro-Barciela, M. | Palom, A. | Buti, M.

CommentOn: Aliment Pharmacol Ther. 2022 Jul;56(1):144-154. - PMID 35514008

2

Hepatitis B Surface Antigen Loss with Tenofovir Disoproxil Fumarate Plus Peginterferon Alfa-2a : Week 120 Analysis

enthalten in: Digestive diseases and sciences | 2018

von Ahn, S. | Marcellin, P. | Ma, X. | +19

ErratumIn: Dig Dis Sci. 2018 Oct 15;:. - PMID 30324553

3

HDV evolution-will viral resistance be an issue in HDV infection?

enthalten in: Current opinion in virology | 2018

von Tabernero, D. | Cortese, M. | Buti, M. | +1

4

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

enthalten in: Journal of hepatology | 2017

von European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu | European Association for the Study of the Liver | Lampertico, P. | +7

5

Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice

enthalten in: Scientific reports | 2017

von Giersch, K. | Homs, M. | Volz, T. | +9

6

Cost-Effectiveness and Clinical Impact of Antiviral Strategies of HBeAg-Positive and -Negative Chronic Hepatitis B

enthalten in: Annals of hepatology | 2017

von Oyagüez, I. | Buti, M. | Brosa, M. | +2

7

Efficacy of a 12-Week Simeprevir Plus Peginterferon/Ribavirin (PR) Regimen in Treatment-Naïve Patients with Hepatitis C Virus (HCV) Genotype 4 (GT4) Infection and Mild-To-Moderate Fibrosis Displaying Early On-Treatment Virologic Response

enthalten in: PloS one | 2017

von Asselah, T. | Moreno, C. | Sarrazin, C. | +12

8

Baseline HCV-RNA levels in genotype 1 chronic hepatitis C patients : The role of different cut-off points

enthalten in: Hepatology (Baltimore, Md.) | 2016

von Buti, M. | Sánchez-Ruano, J. | Morillas, R. | +1

CommentOn: Hepatology. 2016 Aug;64(2):370-80. - PMID 26799692

9

Cost-effectiveness analysis of sofosbuvir, peginterferon and ribavirin in patients with chronic hepatitis C : Early treatment in the initial stage of fibrosis vs. delayed treatment in advanced fibrosis

enthalten in: Gastroenterologia y hepatologia | 2016

von Buti, M. | Domínguez-Hernández, R. | Oyagüez, I. | +1

10

Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

enthalten in: Gastroenterology | 2016

von Marcellin, P. | Ahn, S. | Ma, X. | +28

CommentIn: Gastroenterology. 2016 Jan;150(1):32-4. - PMID 26615120